Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
A Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
GermanyA study to test if tibulizumab works and is safe for adults with systemic sclerosis
HungaryA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
BulgariaStudy of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
AustriaComparison of zasocitinib and deucravacitinib in adults with moderate to severe plaque psoriasis
BulgariaStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
BulgariaStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
AustriaStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
BelgiumStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
BelgiumStudy on IMVT-1402 for Patients with Active Cutaneous Lupus Erythematosus
BulgariaStudy on the Effects of Ritlecitinib in Patients Aged 12 and Older with Alopecia Areata
CzechiaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
